219 related articles for article (PubMed ID: 15940389)
21. [Comparative assessment of clinical features and imaging findings for patients with vascular parkinsonism and idiopathic Parkinson's disease].
Zhao DQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):868-70. PubMed ID: 16027088
[TBL] [Abstract][Full Text] [Related]
22. Vascular parkinsonism--an update.
Rektor I; Rektorová I; Kubová D
J Neurol Sci; 2006 Oct; 248(1-2):185-91. PubMed ID: 16765989
[TBL] [Abstract][Full Text] [Related]
23. [Rehabilitation of gait disorders in patients with Parkinson's disease and vascular parkinsonism].
Pokhabov DV; Abramov VG; Nesterova IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):20-5. PubMed ID: 19365367
[TBL] [Abstract][Full Text] [Related]
24. Assessment of rest tremor in Parkinson's disease.
Budzianowska A; Honczarenko K
Neurol Neurochir Pol; 2008; 42(1):12-21. PubMed ID: 18365958
[TBL] [Abstract][Full Text] [Related]
25. The diagnosis of manganese-induced parkinsonism.
Cersosimo MG; Koller WC
Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
[TBL] [Abstract][Full Text] [Related]
26. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
[TBL] [Abstract][Full Text] [Related]
27. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
[TBL] [Abstract][Full Text] [Related]
28. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
Goetz CG; Stebbins GT; Blasucci LM
Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
[TBL] [Abstract][Full Text] [Related]
29. Characterization of gastrointestinal disorders in patients with parkinsonian syndromes.
Park H; Lee JY; Shin CM; Kim JM; Kim TJ; Kim JW
Parkinsonism Relat Disord; 2015 May; 21(5):455-60. PubMed ID: 25726518
[TBL] [Abstract][Full Text] [Related]
30. Anticardiolipin antibody in vascular parkinsonism.
Huang Z; Jacewicz M; Pfeiffer RF
Mov Disord; 2002 Sep; 17(5):992-7. PubMed ID: 12360548
[TBL] [Abstract][Full Text] [Related]
31. [(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism.
Contrafatto D; Mostile G; Nicoletti A; Dibilio V; Raciti L; Lanzafame S; Luca A; Distefano A; Zappia M
Acta Neurol Scand; 2012 Jul; 126(1):12-6. PubMed ID: 21916850
[TBL] [Abstract][Full Text] [Related]
32. [Vascular or "lower body Parkinsonism": rise and fall of a diagnosis].
Szirmai I
Ideggyogy Sz; 2011 Nov; 64(11-12):385-93. PubMed ID: 22611616
[TBL] [Abstract][Full Text] [Related]
33. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
35. Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism.
de Araújo DF; de Melo Neto AP; Oliveira ÍS; Brito BS; de Araújo IT; Barros IS; Lima JW; Horta WG; Gondim Fde A
BMC Neurol; 2016 Aug; 16():139. PubMed ID: 27530902
[TBL] [Abstract][Full Text] [Related]
36. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
[TBL] [Abstract][Full Text] [Related]
37. Octogenarian parkinsonism - Clinicopathological observations.
Rajput AH; Rajput EF
Parkinsonism Relat Disord; 2017 Apr; 37():50-57. PubMed ID: 28109723
[TBL] [Abstract][Full Text] [Related]
38. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
Benbir G; Ozekmekçi S; Apaydin H; Delil S; Erginöz E
Clin Neurol Neurosurg; 2006 Dec; 108(8):726-32. PubMed ID: 16564615
[TBL] [Abstract][Full Text] [Related]
39. The L-dopa response in vascular parkinsonism.
Zijlmans JC; Katzenschlager R; Daniel SE; Lees AJ
J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):545-7. PubMed ID: 15026493
[TBL] [Abstract][Full Text] [Related]
40. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study.
Yamanouchi H; Nagura H
Stroke; 1997 May; 28(5):965-9. PubMed ID: 9158634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
